My Medication Side Effects Are Too Popular

And these more than three billion assets will also be merged into Xinming Pharmaceutical Company.

After the reorganization of the two companies, the equity will also be redistributed.

The merger of the two drug research and development and experimental centers will be separated from Xinming Pharmaceuticals separately, and it will no longer be related in the future.

In this way, all new drug patents developed in the future will be unique to Fu Liang.

The drug rights before the thousand are still distributed according to the previous ratio

Those shareholders did not leave at the most difficult time of Xinming Pharmaceutical, but everyone put out a sum of money to help the company through the difficulties, and many even

It was borrowed money, and the Fu family did not directly kick them out after they developed.

Relying on the sales of the previous drugs, each of them has the opportunity to receive billions, or even tens of billions.

But some new drugs have nothing to do with them anymore.

"Dad, what is the good news for going to the capital this time?

"This year's major new drug creation special award, we won." Speaking of this, Fu Xinming's expression was a little excited

Song He of the Provincial Food and Beverage Supervision Bureau said that he had reported it to the newspaper, and he had a great chance of winning the prize, and he was looking forward to it at that time.

After getting the oar straight, he felt everything was so dreamy.

In the past, he could only watch other pharmaceutical companies win such awards, and they were all large state-owned pharmaceutical companies.

Because these pharmaceutical companies have capital, technology, and guidance from many top domestic experts,

In general, small pharmaceutical companies

, all rely on some improved ancient Chinese medicine to have the opportunity to win the prize.

And even if he won the prize, he was also ranked last.

This time, Xinming Pharmaceutical's Supain has won the grand prize, ranking first among all the selected drugs, surpassing some drugs for the treatment of cancer!

This is still a drug that has not been successfully marketed, and it has won an award for the first time in history!

Fu Liang was also a little excited: "Dad, after winning the award, is there any benefit?

What's the use of only a false name, Fu Liang still felt that the real benefits were more important.

ask for flowers

Just like when the class gave out awards when he was a child, in Fu Liang's opinion, it might be better to give out a pen.

Fu Xinming glanced at his son: "You want benefits in everything.

"Of course there are benefits. In the future, our drug application for clinical trials will be given priority for approval.

"As mentioned above, it will help our new drugs enter overseas markets.

Their quick stop is in cooperation with Johnson & Johnson, so don't worry about sales in overseas markets

However, new drugs such as hair growth drugs are produced and sold by themselves, and there are many difficulties.

If it wasn't for Johnson & Johnson to help with the clinical practice, the overseas clinical practice alone would have been blocked by those top pharmaceutical companies.

Most of the world's top pharmaceutical companies are located in Europe and the United States. Before Asia, only a few pharmaceutical companies in Neon and a few from Asan could rank first.

Xuehong has a good foundation, but Asan is completely shameless.

On Asan's side, for any medicine that can cure diseases and save lives, they can disobey the international patent convention.

Therefore, Asan's generic drugs are unique in the world and have no rivals.

There is basically only one way for some top pharmaceutical companies to enter the Asan market, and that is patent licensing.

If you don't authorize it, others will imitate it, and you won't get anything.

It's better to authorize a patent. Although the price is extremely low, you can earn a little back.

Xinming Pharmaceutical wants to promote hair growth drugs, but the top pharmaceutical companies in Europe and the United States seem to have agreed, but they are all obstructing.

Their purpose is very clear, that is, they want Xinming Pharmaceutical to license patents to them, or let them take shares in these new drug projects, so as to get a share of the pie.

Local protectionism is not only found in developing countries, but even worse in many developed countries!

Therefore, the promise above is indeed very important to Xinming Pharmaceutical.

The markets occupied by top pharmaceutical companies are also markets with high per capita income and cannot be given up.

Although many people said at this time that Xinming Pharmaceutical has a production value of hundreds of billions in the future, it is just like the valuation of many companies, after all, it is only false

It's much harder than you think to make real money.

"Dad, did the above say how to help?

Fu Xinming sat down and lit a cigarette: "The above said that most of our country's medicines were imported before, because our western medicine developed relatively late.

Chinese medicine is not recognized abroad

"So this time there is a drug that has been recognized by foreign countries and has significant effects. They will do their best to help promote it and get it for production in various countries as soon as possible.

Approval, so that we can start production as soon as possible.

"They will communicate at the political axe level, but the obstruction of the top pharmaceutical companies needs to be handled by ourselves.

Fu Gao frowned slightly, so the help was not strong enough.

If he wants to break through the joint blockade of top foreign pharmaceutical companies, he must first kill a chicken and become a monkey

Fearing a top pharmaceutical company and letting them back down can only let other pharmaceutical companies know that it is absolutely okay to prevent Xinming Pharmaceutical from expanding in such a slow way.

No way!

And once Xinming Pharmaceutical counterattacks, it will hurt them even more!

Fu Liang took a look, and the one who blocked them the most was Pfizer.

Well, let's start with Pfizer.

PS: Ask for flowers, ask for evaluation, ask for automatic subscription!!!

Chapter [-]: Take all of Pfizer's market!

On the board of directors of Rui Company, the expressions on the faces of the directors are relatively relaxed.

Chairman Eberle looked at Williams: "Williams, the eastern market you have vigorously developed is developing very well, and this time you made [-] million US dollars in vain.

"The company will be able to make more money in the eastern market in the future, but there is such a strong competitor as Xinming Pharmaceutical.

Williams holds the coffee cup in his hand:

"But don't worry, Xinming Pharma not only refused our cooperation, but also refused to cooperate with Johnson & Johnson again. At the same time, it has not cooperated with other top

Pharmaceutical company cooperation.

New Proposal When we blocked Xinming Pharmaceutical, other pharmaceutical companies responded one after another, and even Johnson & Johnson did not speak out for Xinming Pharmaceutical.

Drinking Niu Company is at a disadvantage in the confrontation with their Pfizer, let alone the joint confrontation with the world's top pharmaceutical companies.

At present, most of the energy of Qiangniu is on the project of quick stop, which is the most important thing for Johnson & Johnson.

Xinming Pharmaceutical is not willing to take out other projects to cooperate with strong "[-]" students. Why should Johnson & Johnson offend other pharmaceutical companies for Xinming Pharmaceuticals?

There is competition and cooperation among the world's top pharmaceutical companies.

However, under normal circumstances, they cooperate with foreign pharmaceutical companies, and rarely cooperate with domestic pharmaceutical companies.

Cooperation with foreign pharmaceutical companies can help them better develop overseas markets and local markets, and they have the ability to develop.

The rest of Pfizer's directors were very pleased with Williams' approach, which could thwart Xinming's new drug launch and even prolong Xinming.

Pharmacy new drug clinical time.

The longer the clinical time, the higher the likelihood of an accident

In case a certain drug is clinically tested in a certain country, severe allergies are found, or some previously undiscovered side effects are found

It is a major blow to the new drugs of Xinming Pharmaceutical!

Even if there is none, it will slow down the development of Xinming Pharmaceutical, allowing them to develop alternative medicines and regain the market.

"Williams, what we need most now is to keep our existing market, new drug development for the treatment of ED, is there any progress?

This is what all shareholders are concerned about. After all, Viagra has brought them extremely rich profits before.

Williams shook his head regretfully: "I'm sorry to inform you that we have focused on developing drugs for the treatment of cancer in recent years.

"We have also increased cooperation with some companies that produce medical devices, and we have also funded some laboratories and funded some top doctors.

, The only thing that can compete with us is our generic drugs

"Our Viagra has never had a competitor in the market before,

But the onset of generic drugs is slower than ours, because the pharmaceutical technology is not as good as ours, and our drugs are more expensive, but they are still the first choice for all men

"It's just that the drug released by Xinming Pharmaceutical has performed very well, although our drug can also be used as a prescription for the treatment of pulmonary arterial hypertension.

But there will inevitably be a major impact, we are not opponents.

The joyful mood of the directors just now disappeared, and it is not that Pfizer has not lost in the drug competition.

The losers are all the world's top pharmaceutical companies, whose R&D investment and technical strength are not much worse than their Pfizer.

Occasionally a new special medicine emerges, which is more effective than their Pfizer products.

After all, no one medicine can produce all kinds of medicines, and there is always a focus.

But they, Pfizer, had been the dominant player in the ED treatment market for [-] years, and were suddenly told that their position was about to move.

, but to be kicked directly from the high platform, how can you bear it?

But they are doing research and development now, and it is too late to compete with the new drug of Xinming Pharmaceutical, and they will inevitably lose soon.

So to keep the market,

To preserve profits, it is necessary to use some other methods.